Hong Kong Approves Sinovac Vaccine for Children Aged 3-17

Medicine & Technology Nov 20, 2021

Adolescents aged 12 to 17 will be given priority in receiving the Sinovac COVID-19 vaccination in Hong Kong, with younger children receiving the vaccine later.

COVID-19 Delta Variant Spreads Fast; More Travelers From Abroad Want Another Vaccine Booster Shot in the US

Aug 17, 2021

More and more travelers have been having or at least planning to get another shot of the COVID-19 vaccine in fear of getting infected by the fast-spreading COVID-19 Delta variant.

BioNTech More Effective Than Sinovac, Study Shows It Has 10 Times More Antibodies

Jul 16, 2021

Research recently showed those who have received the BioNTech COVID-19 vaccine have 10 times more antibodies compared to those who were given Sinovac.

'Project S': How Does This Vaccination Experiment Work in Small Brazilian City?

Jun 06, 2021

Brazilian city Serrana residents have regained hope after researchers recently vaccinated nearly its whole adult population via the "Project S" in a city-wide vaccination experiment this spring.

COVID-19 Vaccine: WHO Issued Emergency Approval for China's Coronavac, After Meeting International Standards

Jun 03, 2021

The World Health Organization (WHO) gives emergency approval for China's COVID-19 vaccine, called CoronaVac, that is manufactured by SinoVac. This assures countries that it has met international standards for safety, efficacy, and manufacturing.

Sinopharm COVID Vaccine Gets WHO Emergency Approval: Why Does This Matter?

May 08, 2021

The World Health Organization validated the "safety, efficacy, and quality of the COVID-19 vaccine of the Chinese state-owned Sinopharm, giving them emergency approval.

WHO Declares China's Sinovac Effective, Yet Questions Remain

May 06, 2021

The World Health Organization has declared China's Sinovac vaccine as efficacious in preventing COVID-19 in adults 18 to 59 years old, yet the health body notes the lack of quality data on adverse effects on high-risk groups.

Anvisa Gives Green Light to SinoVac For Clinical Trials to Resume

Nov 12, 2020

SinoVac is the third pharmaceutical company to halt and resume clinical trials after a volunteer suffered a severe adverse event.

CoronaVac Phase Three Trials in Brazil Paused

Nov 10, 2020

Clinical trials are temporary on hold in Brazil after a volunteer experienced a severe adverse event.

Vaccine Candidates in the Middle of Phase 3 Trials Are Available for the Public

Oct 22, 2020

China is already in the middle of their post-Covid new normal as if the pandemic is already gone. Currently, several companies have made their vaccine candidates available to anyone upon payment.

China Commits to Producing 600 Million Vaccine Doses by the End of 2020

Oct 10, 2020

China joins COVAX and commits to providing several developing countries with millions of vaccine doses. The four leading vaccine candidates from China are for the global public good.

Sinovac 99% Confident that 'CoronaVac' Will Work Effectively Against Coronavirus

Jun 01, 2020

Chinese company, Sinovac Biotech Ltd has arrived at the stage 2 trial of CoronaVac with more than 1,000 volunteers in the study.